UPDATED Apr 24, 2024
Potentially undervalued companies with a strong past performance and robust balance sheet.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NOVO B | kr.878.70 | 0.8% | 58.2% | kr.3.9t | kr.904.20 | PE46.8x | E14.7% | 1.1% | Pharmaceuticals & Biotech |